Skip to main content
Signal8

Zalevsky Jonathan

SEC insider (Form 3/4/5 filer). CIK 0001789857. Chief R&D Officer at NEKTAR THERAPEUTICS (NKTR). 22 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in SAN FRANCISCO, CA.

Companies Zalevsky Jonathan has filed insider reports for

  • NEKTAR THERAPEUTICS (NKTR): Officer, Chief R&D Officer
Zalevsky Jonathan profile photo

Zalevsky Jonathan

CIK: 0001789857

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (77.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (22.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NEKTAR THERAPEUTICS logo
NKTR

NEKTAR THERAPEUTICS

Officer

Discretionary Trading P&L

Holdings

Transaction History (22 total)

  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Aug 18, 2026
    Sale
    Direct
    186 shares at avg. $71.98$13K
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Jul 24, 2026
    Award

    Stock Option

    Direct
    16.5K shares-
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Jun 30, 2026
    Sale
    Direct
    5.7K shares at avg. $70.00$398K
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Jun 15, 2026
    Sale
    Direct
    5.5K shares at avg. $60.71$336K
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    May 19, 2026
    Sale
    Direct
    199 shares at avg. $65.51$13K
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Feb 18, 2026
    Sale
    Direct
    180 shares at avg. $73.00$13K
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Jan 20, 2026
    Sale
    Direct
    3.9K shares at avg. $35.67$138K
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Dec 22, 2025
    Award
    Direct
    6.3K shares-
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Nov 25, 2025
    Sale
    Direct
    1.2K shares at avg. $54.28$63K
  • NEKTAR THERAPEUTICS logo
    NKTR

    NEKTAR THERAPEUTICS

    Nov 21, 2025
    Award
    Direct
    2.7K shares-

1-10 of 22